Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.

Drew W RascoTheresa MedinaPippa CorrieAnna C PavlickMark R MiddletonPaul LoriganChris HebertRuth PlummerJames LarkinSanjiv S AgarwalaAdil I DaudJiaheng QiuViviana BozonMichelle KneisslElly BarryAnthony J Olszanski

Published in: Cancer chemotherapy and pharmacology (2023)

NCT01425008.

Keyphrases

open label
double blind
placebo controlled
clinical trial